INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (410, 27847, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'dietary fiber', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (411, 28165, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'dietary fiber', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (412, 28633, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'dietary fiber', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (413, 4490, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (414, 4491, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (415, 4492, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (416, 11401, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (417, 18658, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (418, 18659, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (419, 27846, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (420, 27847, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (421, 28165, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (422, 28633, 'Levothyroxine', 'Consumption of certain foods as well as the timing of meals relative to dosing may affect the absorption of T4 thyroid hormone (i.e., levothyroxine).  T4 absorption is increased by fasting and decreased by foods such as soybean flour (e.g., infant formula), cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices.', 'soybean', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4f4b6e033108bd0acb44b2bcea0d7a855e80b17186c886cae0a473fbd8a32aca0ac1fbf2ad62a3fd3aab801648d41d59a0a86603347852ad6bfa4ee0dc586e8bd608ab41a78ace8f092864b585353c004ba1e4a70237d3fe36fff99ac7a32b67d8b53715820b478a012a3df484fe58e81a61513fb46cc0923aa15186ed8082e62b0d2543a64fe0ac6d23edabb3e9b111ce67aa8e0e178ab719c552507c327b1b15af0192bacf0ca369b1fe0af0c42ac32d406672ecd39637ea938935f168e1ccfd5f969173e129be0f4e64f105d8237979');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (424, 6693, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (425, 14737, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (426, 22757, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (427, 22758, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d505d4e04210cbe4a0fa07b07e3bb31f1045da6b334423b9632eb787a0babab0f2450be7e7fafe84ce20d8c12f1ce7281e797b7474cce3b015ee65fcbdacb0267822b9ad002ba82676ec0e26403ab02280be0b2738b7f57c05d398006852b3b2495d6eb3691b18d2569d6720278aae75ed0d50ed87ebdfce925edd2a8fca7ccf885b6686f304d72ec0cf71f9d6db84f5ab7424e50830a4b2891b9506bd360d5500a8cdac282d34d17e71271e88077d12be438f16af7f4b8ae947ccceac324092ba2ceeb31666cb0e5a3716214e0f546449f1b59644914d714e2a3cc10de4c8bca25e244c94093b8c50afaadca952c3a66cf3fcca25647867bd0d337690fa19b', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (428, 22759, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (429, 22760, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (430, 22761, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (431, 22762, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (432, 23184, 'Levomilnacipran', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d505d4e04210cbe4a0fa07b07e3bb31f1045da6b334423b9632eb787a0babab0f2450be7e7fafe84ce20d8c12f1ce7281e797b7474cce3b015ee65fcbdacb0267822b9ad002ba82676ec0e26403ab02280be0b2738b7f57c05d398006852b3b2495d6eb3691b18d2569d6720278aae75ed0d50ed87ebdfce925edd2a8fca7ccf885b6686f304d72ec0cf71f9d6db84f5ab7424e50830a4b2891b9506bd360d5500a8cdac282d34d17e71271e88077d12be438f16af7f4b8ae947ccceac324092ba2ceeb31666cb0e5a3716214e0f546449f1b59644914d714e2a3cc10de4c8bca25e244c94093b8c50afaadca952c3a66cf3fcca25647867bd0d337690fa19b', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (433, 5730, 'Linagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (434, 21837, 'Linagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (435, 24136, 'Linagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (436, 25214, 'Linagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c6592c18edb300c447f85c716c806e89e7add02057ae9ad3f40cbb42554125d4a4aeabfefd069b6097a32645b33c3377ccb41a3662abc53e0d184e2bee99af7202531a9f959ecfd45aab4714f527ba36bea91e6c493746967a26f8f378bb64e8bc9af817ff34e1ac2b046f3b05457e230ba50d0da46d97ad24aba10dfb240e9eb452a14668106171dee16b852d6ab184d5975a63656366a69ad6949f808931349db2424ce30bc4668f42877594a0de95748ca4c30849cc07ba7d6b570883eeba219161e507e8b85d404617e40a348885c532b90b868be886bc534a57bf649c162cd032389ae52a5c18ec14872f6a707093e88d88bc93a3277b59d0c810141a8eb137867b0a5e6045cfda913af2ab3d345e2cf7ef3d32b4575babc409fa423ab0f7c4c8b8050fbb23bed6eb877a2104d6b0aef6478f2e21df06d0552d93819301d031de9b218d70098757ede08687f474ce3fe8ff463afcec28e4266c53055d1e8b248e87f6bbc5b64b9486effefd701f0888e6e10e961dfde7068232fc9b8bce4f4538093c3e1fa41ceebf9444b1e2d02c389a2f08c92e5744c507d4cfee8ecee99234a9a042b63b2a9f98e3c2cef91c42b743ae823c4acb6996e5cd27c837211af934deebf6321d085e7d3bae78168edfc07c65d4565');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (437, 28383, 'Linagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (439, 12971, 'Liraglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (440, 12972, 'Liraglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (442, 27247, 'Lixisenatide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (443, 27248, 'Lixisenatide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c6592c18edb300c447f85c716c806e89e7add02057ae9ad3f40cbb42554125d4a4aeabfefd069b6097a32645b33c3377ccb41a3662abc53e0d184e2bee99af7202531a9f959ecfd45aab4714f527ba36bea91e6c493746967a26f8f378bb64e8bc9af817ff34e1ac2b046f3b05457e230ba50d0da46d97ad24aba10dfb240e9eb452a14668106171dee16b852d6ab184d5975a63656366a69ad6949f808931349db2424ce30bc4668f42877594a0de95748ca4c30849cc07ba7d6b570883eeba219161e507e8b85d404617e40a348885c532b90b868be886bc534a57bf649c162cd032389ae52a5c18ec14872f6a707093e88d88bc93a3277b59d0c810141a8eb137867b0a5e6045cfda913af2ab3d345e2cf7ef3d32b4575babc409fa423ab0f7c4c8b8050fbb23bed6eb877a2104d6b0aef6478f2e21df06d0552d93819301d031de9b218d70098757ede08687f474ce3fe8ff463afcec28e4266c53055d1e8b248e87f6bbc5b64b9486effefd701f0888e6e10e961dfde7068232fc9b8bce4f4538093c3e1fa41ceebf9444b1e2d02c389a2f08c92e5744c507d4cfee8ecee99234a9a042b63b2a9f98e3c2cef91c42b743ae823c4acb6996e5cd27c837211af934deebf6321d085e7d3bae78168edfc07c65d4565');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (444, 27247, 'Lixisenatide', 'Lixisenatide slows gastric emptying, which may impact the absorption of concomitantly administered oral medications.  The interaction has been studied with various medications, which demonstrated primarily an effect on the rate rather than the overall extent of absorption.', 'food', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4fdb8d0331086c650a38a592fbbc0688cdc64836ac0cc966bb0f5614e57e9006e6c5af3cc55929a432bcdbe1b891c794021e7b9ca2b71f1c4d4ac3a01332762a81680cbabacd3dc414b6a198161b12a4d14f501da2e2c1932b6c52c7e02a8516db2fc05fea45f39c66cba091e3caacf0b85749cd21d1f0a02976f7ffda4f97ca23514c8a24ef53465257ae82b78db3619aae928bb046e39998de4b7b6470efe067b0c66afffde5f202364166a3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (445, 27248, 'Lixisenatide', 'Lixisenatide slows gastric emptying, which may impact the absorption of concomitantly administered oral medications.  The interaction has been studied with various medications, which demonstrated primarily an effect on the rate rather than the overall extent of absorption.', 'food', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d4fdb8d0331086c650a38a592fbbc0688cdc64836ac0cc966bb0f5614e57e9006e6c5af3cc55929a432bcdbe1b891c794021e7b9ca2b71f1c4d4ac3a01332762a81680cbabacd3dc414b6a198161b12a4d14f501da2e2c1932b6c52c7e02a8516db2fc05fea45f39c66cba091e3caacf0b85749cd21d1f0a02976f7ffda4f97ca23514c8a24ef53465257ae82b78db3619aae928bb046e39998de4b7b6470efe067b0c66afffde5f202364166a3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (446, 6423, 'Loperamide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (447, 22017, 'Loperamide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d505d4e04210cbe4a0fa07b07e3bb31f1045da6b334423b9632eb787a0babab0f2450be7e7fafe84ce20d8c12f1ce7281e797b7474cce3b015ee65fcbdacb0267822b9ad002ba82676ec0e26403ab02280be0b2738b7f57c05d398006852b3b2495d6eb3691b18d2569d6720278aae75ed0d50ed87ebdfce925edd2a8fca7ccf885b6686f304d72ec0cf71f9d6db84f5ab7424e50830a4b2891b9506bd360d5500a8cdac282d34d17e71271e88077d12be438f16af7f4b8ae947ccceac324092ba2ceeb31666cb0e5a3716214e0f546449f1b59644914d714e2a3cc10de4c8bca25e244c94093b8c50afaadca952c3a66cf3fcca25647867bd0d337690fa19b', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (448, 22019, 'Loperamide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (449, 27540, 'Loperamide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (450, 30846, 'Loperamide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (451, 7430, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (452, 7432, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (453, 10527, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (454, 12818, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (455, 12820, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (456, 22401, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (457, 22402, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (458, 27051, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (459, 27052, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (460, 29893, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (461, 33638, 'Lisinopril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (462, 7430, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (463, 7432, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (464, 10527, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (465, 12818, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (466, 12820, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (467, 22401, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (468, 22402, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (469, 27051, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (470, 27052, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (471, 29893, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (472, 33638, 'Lisinopril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (473, 5798, 'Lithium carbonate', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (474, 25225, 'Lithium carbonate', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (475, 2702, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (476, 2703, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (477, 7525, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (478, 7530, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (479, 8338, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (480, 13780, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (481, 13784, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (482, 13785, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (483, 20512, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (484, 22027, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (485, 22030, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (486, 22031, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'789c4d90414e03310c45afe22548a542a21ca0ea05102a0b969ec4d39866e2c1715a86d3e35485b28be36ffbfdbf4f042173e180192a1f0a8ffe2c814046b0c41566312ac6dee662a4188ca580375a3916399735c02bcda246f1bfa2c2992d5da761f7feb2797e84a7edc635890736d10a998ffd3aaa2b55a625705901e9f25701960847320952f05b3241c213c1ac125bf07bb50dd5f0972e2861a5ea2f2727402f1d32925eca39639d107c537022c50ef9603c3941535f7ab77ddbdd77d759bc89910b5dceb355e8965c3291e120998d5610a906d441c8927c2db799d5c5b73403ac550263cf25242c871b999c3ca5ec79e348b6743b23e76be20451db61bd4fa4348afabe22803172e7759bae509ca91907fffe68d526b7e369bb1e943e1b2bc5f50f80c4afca', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (487, 22032, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (488, 22033, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'789c4d90414e03310c45afe22548a542a21ca0ea05102a0b969ec4d39866e2c1715a86d3e35485b28be36ffbfdbf4f042173e180192a1f0a8ffe2c814046b0c41566312ac6dee662a4188ca580375a3916399735c02bcda246f1bfa2c2992d5da761f7feb2797e84a7edc635890736d10a998ffd3aaa2b55a625705901e9f25701960847320952f05b3241c213c1ac125bf07bb50dd5f0972e2861a5ea2f2727402f1d32925eca39639d107c537022c50ef9603c3941535f7ab77ddbdd77d759bc89910b5dceb355e8965c3291e120998d5610a906d441c8927c2db799d5c5b73403ac550263cf25242c871b999c3ca5ec79e348b6743b23e76be20451db61bd4fa4348afabe22803172e7759bae509ca91907fffe68d526b7e369bb1e943e1b2bc5f50f80c4afca', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (489, 22041, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (490, 22993, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (491, 26628, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (492, 26629, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (493, 26681, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (494, 28731, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (495, 28732, 'Loratadine', 'Theoretically, grapefruit juice may increase the plasma concentrations of loratadine as it does other drugs that are substrates of the CYP450 3A4 enzymatic pathway.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', '', 'DDInter', 0, X'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', NULL, X'789c45904b6ec3300c05aff20ed004059a1ea0e805bac8a64b5aa26d16d607a48440397d296fb2d4676644dd772eca4d021dc778c3a65479d52e0d7f5d0223d180e4a04cc6683ba31e6489104a0e9c9b5293920d65c5517c415132830c2e8885fdc01945d4be99e3d440cab0bed844f904a7f5fbf7e7f6f98e8faf1b383f47726d40a5b63f685c81fb0c6ba9c5382271d8298b258877f22e8bcc474cd54b73491cc50b11aba8b54b2533271b2de538d17c76b7def0f0d1b10c04d646be1f4aaaa5e7689e64f321e7e5d7c7d8f51feb9a6ff3');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (497, 871, 'Lorazepam', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (504, 1162, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (505, 6221, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (506, 7329, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (507, 7330, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (508, 12965, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (509, 13118, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (510, 13322, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (511, 14745, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c4d91416e03310845afc2b295a6b9433695baa8b2e905b0878c91c6601926cde4f4c553a9e9d2f0ffe781df5567032fe890551c5960c5be1060d54ddc40afe07bc7ca42507187d6297363470f0d94bd517712e31b41ee6c6c10110d9d69b8bd530867f8662f5055f43748ef3ca351480b2776ed062f9fe7cb87bd9e00be4a4ca25c50d82a1c81878a55064de8dece532013903cf64ad0c99a06425a09aedac3ec9874e507cb0274d78544378363b4816db900da73abe01d61cbe680328f056fc13ebc51ae70ed5a21d1786332ed29d6e1b854f660bd48a6bff2f42fd39e14a17705cdaeed684e7137db92390ef371fa90275a39061fda99adad184dd14e2d2cadf4917aa0589c0be383968eb2ad64a71f0f9ea69e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (512, 14747, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c4d91416e03310845afc2b295a6b9433695baa8b2e905b0878c91c6601926cde4f4c553a9e9d2f0ffe781df5567032fe890551c5960c5be1060d54ddc40afe07bc7ca42507187d6297363470f0d94bd517712e31b41ee6c6c10110d9d69b8bd530867f8662f5055f43748ef3ca351480b2776ed062f9fe7cb87bd9e00be4a4ca25c50d82a1c81878a55064de8dece532013903cf64ad0c99a06425a09aedac3ec9874e507cb0274d78544378363b4816db900da73abe01d61cbe680328f056fc13ebc51ae70ed5a21d1786332ed29d6e1b854f660bd48a6bff2f42fd39e14a17705cdaeed684e7137db92390ef371fa90275a39061fda99adad184dd14e2d2cadf4917aa0589c0be383968eb2ad64a71f0f9ea69e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (513, 14748, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (514, 14879, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (515, 17141, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (516, 17142, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (517, 21121, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (518, 21122, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (519, 21848, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (520, 21849, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (521, 21850, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'789c6d545b8ee4360cbc0a3f7701678000b9c0225ffb1124407201b644b7899645ad1eddf19c3e45b97b920d168399b16c8a2c5615f935d355b2544e0b15ee2ab937ea55b84ba487f68d7efbf2fbd74656c9fa2695f87a866cdca9586bd2da0c210e5defda0ffa246fd7b785d651f9dd9246cbb250d22cf38432d502d70bbfe3d5676a9b8d1489efa69182e536f6d2d532d9ea91718457357cecac9912d7ab10ef361c08c27847a6469ca3dfe88298d52c36c2c363d3b001b4e6abf7704167b7688f57fa19ac8d4643bbdd702320a209ad0988ea1bd15f9bf8f1992fa41185c226fef253e1da350c004a07b55e2d5f1727287a296f13e4e07086b7cf0b351b95bcc2be80dcfcff1475720e5616dce1bdf0d5a9bb8854b0a6e196f01d1a549d7572d8ecaed210cc7765c4b4adea5ea063eb93f23bf4fabe42001d37c9e737948915c0793480c6754ea012f956bde26f656d9af170e18c1f3c8092c0d1bce266c1127b996633459848395318357aae21f55679f4850ebb8edadd5f850ffe5075a11d36a32e394ad577a95e99ef7ca629207cf99048feee95e79d03f2f4ff9c5df5a8d2d93b19a524d9dda050ee575e577192773e8853336493a0453b70d37614a9a8ddc0042441ab0dad907697b9f34d5ecebc208166dd8110366df4909490fd4ba734a1fcfc0b453eda2b5c1297699894ece1ae8bdadcb99a07bf7c3de7c5a789cb81fcab55f1e387cf1c30ca9ed32011d5fe2c40ce090a46690a5b449865952a39787f1d04a2c3efc898b7533f8b322aa079db77673b7aa773a6403417905c701fa4f8fdc6abcc24b05576182571ce13c51faf05f12f351ceffa9c1da4c1e8fa2488dca06dd4c089b883e48941576ff28076605e27f262f323c2bca9137f3b90c5f673b27f2cd3f091c67f8189a1a47064ccd8428032900b8cf78105830a3048d47575ff6333f54df36d0e0f028aaf344ca3ed8cb3e8fba87396a003361b16cd4223036bc2231acc981261bf71b75dfb7304e31cfb9bfc94d41df384fe03aaa6ffa6a62337f141ced69d35647daed8b96d3905db2c9db9f1f9dc8b1bbf738d36da6bcb62eca1e7b7a1be0bbc07f81efab9f59df304ceb26f66cfb25b9f7d5a8d9a4f3b60736a3ad5b8657bd086dfd380cff5eea313babfdbdffe01f4764078', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (522, 21851, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (523, 24390, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'789c6d545b8ee4360cbc0a3f7701678000b9c0225ffb1124407201b644b7899645ad1eddf19c3e45b97b920d168399b16c8a2c5615f935d355b2544e0b15ee2ab937ea55b84ba487f68d7efbf2fbd74656c9fa2695f87a866cdca9586bd2da0c210e5defda0ffa246fd7b785d651f9dd9246cbb250d22cf38432d502d70bbfe3d5676a9b8d1489efa69182e536f6d2d532d9ea91718457357cecac9912d7ab10ef361c08c27847a6469ca3dfe88298d52c36c2c363d3b001b4e6abf7704167b7688f57fa19ac8d4643bbdd702320a209ad0988ea1bd15f9bf8f1992fa41185c226fef253e1da350c004a07b55e2d5f1727287a296f13e4e07086b7cf0b351b95bcc2be80dcfcff1475720e5616dce1bdf0d5a9bb8854b0a6e196f01d1a549d7572d8ecaed210cc7765c4b4adea5ea063eb93f23bf4fabe42001d37c9e737948915c0793480c6754ea012f956bde26f656d9af170e18c1f3c8092c0d1bce266c1127b996633459848395318357aae21f55679f4850ebb8edadd5f850ffe5075a11d36a32e394ad577a95e99ef7ca629207cf99048feee95e79d03f2f4ff9c5df5a8d2d93b19a524d9dda050ee575e577192773e8853336493a0453b70d37614a9a8ddc0042441ab0dad907697b9f34d5ecebc208166dd8110366df4909490fd4ba734a1fcfc0b453eda2b5c1297699894ece1ae8bdadcb99a07bf7c3de7c5a789cb81fcab55f1e387cf1c30ca9ed32011d5fe2c40ce090a46690a5b449865952a39787f1d04a2c3efc898b7533f8b322aa079db77673b7aa773a6403417905c701fa4f8fdc6abcc24b05576182571ce13c51faf05f12f351ceffa9c1da4c1e8fa2488dca06dd4c089b883e48941576ff28076605e27f262f323c2bca9137f3b90c5f673b27f2cd3f091c67f8189a1a47064ccd8428032900b8cf78105830a3048d47575ff6333f54df36d0e0f028aaf344ca3ed8cb3e8fba87396a003361b16cd4223036bc2231acc981261bf71b75dfb7304e31cfb9bfc94d41df384fe03aaa6ffa6a62337f141ced69d35647daed8b96d3905db2c9db9f1f9dc8b1bbf738d36da6bcb62eca1e7b7a1be0bbc07f81efab9f59df304ceb26f66cfb25b9f7d5a8d9a4f3b60736a3ad5b8657bd086dfd380cff5eea313babfdbdffe01f4764078', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (524, 24391, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (525, 25918, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (526, 29354, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (527, 29606, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (528, 29607, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c4d91416e03310845afc2b295a6b9433695baa8b2e905b0878c91c6601926cde4f4c553a9e9d2f0ffe781df5567032fe890551c5960c5be1060d54ddc40afe07bc7ca42507187d6297363470f0d94bd517712e31b41ee6c6c10110d9d69b8bd530867f8662f5055f43748ef3ca351480b2776ed062f9fe7cb87bd9e00be4a4ca25c50d82a1c81878a55064de8dece532013903cf64ad0c99a06425a09aedac3ec9874e507cb0274d78544378363b4816db900da73abe01d61cbe680328f056fc13ebc51ae70ed5a21d1786332ed29d6e1b854f660bd48a6bff2f42fd39e14a17705cdaeed684e7137db92390ef371fa90275a39061fda99adad184dd14e2d2cadf4917aa0589c0be383968eb2ad64a71f0f9ea69e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (529, 29608, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (530, 30068, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (531, 32064, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (532, 32789, 'Linezolid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (534, 5593, 'Acarbose', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'789c6592c18edb300c447f85c716c806e89e7add02057ae9ad3f40cbb42554125d4a4aeabfefd069b6097a32645b33c3377ccb41a3662abc53e0d184e2bee99af7202531a9f959ecfd45aab4714f527ba36bea91e6c493746967a26f8f378bb64e8bc9af817ff34e1ac2b046f3b05457e230ba50d0da46d97ad24aba10dfb240e9eb452a14668106171dee16b852d6ab184d5975a63656366a69ad6949f808931349db2424ce30bc4668f42877594a0de95748ca4c30849cc07ba7d6b570883eeba219161e507e8b85d404617e40a348885c532b90b868be886bc534a57bf649c162cd032389ae52a5c18ec14872f6a707093e88d88bc93a3277b59d0c810141a8eb137867b0a5e6045cfda913af2ab3d345e2cf7ef3d32b4575babc409fa423ab0f7c4c8b8050fbb23bed6eb877a2104d6b0aef6478f2e21df06d0552d93819301d031de9b218d70098757ede08687f474ce3fe8ff463afcec28e4266c53055d1e8b248e87f6bbc5b64b9486effefd701f0888e6e10e961dfde7068232fc9b8bce4f4538093c3e1fa41ceebf9444b1e2d02c389a2f08c92e5744c507d4cfee8ecee99234a9a042b63b2a9f98e3c2cef91c42b743ae823c4acb6996e5cd27c837211af934deebf6321d085e7d3bae78168edfc07c65d4565');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (535, 24143, 'Acarbose', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (536, 8332, 'Apomorphine', 'Alcohol and apomorphine may have additive hypotensive and sedative effects.  Coadministration of 0.6 or 0.3 g/kg of ethanol with apomorphine in healthy subjects resulted in greater decreases in blood pressure compared to apomorphine alone.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcc810d80200c04c0557e026771856aab34813e81c2fc7a03dc29e91639310b57555c06d1edd31449c8a62b6ec65cada733c007526f1656e81a1e2fa4b371f4e261c86192edff8e0fc6952178', NULL, X'789c558d510ec2300c43afe2130c2424fe1127c9d66c29b44dd564a0dd9e96bf7dd9f2b3ec475a5434814a0055cddaaac4c2c87440e8c3a010a2c76ee4a8ea5c6cf8d1360ef407bcaebcb84dc05329e458a279eb480b74c575ba435b971bb6cb7b1b11bb50e99fdfe8723a8d05c2945c0ed83ebfc62a1adb9e9cc3805b63726e08bc74676c239c936a40ed3ddb1b63d15ca9f5beeb699b92169e7ef17057c8');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (537, 22989, 'Apomorphine', 'Alcohol and apomorphine may have additive hypotensive and sedative effects.  Coadministration of 0.6 or 0.3 g/kg of ethanol with apomorphine in healthy subjects resulted in greater decreases in blood pressure compared to apomorphine alone.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcc810d80200c04c0557e026771856aab34813e81c2fc7a03dc29e91639310b57555c06d1edd31449c8a62b6ec65cada733c007526f1656e81a1e2fa4b371f4e261c86192edff8e0fc6952178', NULL, X'789c558d510ec2300c43afe2130c2424fe1127c9d66c29b44dd564a0dd9e96bf7dd9f2b3ec475a5434814a0055cddaaac4c2c87440e8c3a010a2c76ee4a8ea5c6cf8d1360ef407bcaebcb84dc05329e458a279eb480b74c575ba435b971bb6cb7b1b11bb50e99fdfe8723a8d05c2945c0ed83ebfc62a1adb9e9cc3805b63726e08bc74676c239c936a40ed3ddb1b63d15ca9f5beeb699b92169e7ef17057c8');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (538, 23054, 'Apomorphine', 'Alcohol and apomorphine may have additive hypotensive and sedative effects.  Coadministration of 0.6 or 0.3 g/kg of ethanol with apomorphine in healthy subjects resulted in greater decreases in blood pressure compared to apomorphine alone.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcc810d80200c04c0557e026771856aab34813e81c2fc7a03dc29e91639310b57555c06d1edd31449c8a62b6ec65cada733c007526f1656e81a1e2fa4b371f4e261c86192edff8e0fc6952178', NULL, X'789c558d510ec2300c43afe2130c2424fe1127c9d66c29b44dd564a0dd9e96bf7dd9f2b3ec475a5434814a0055cddaaac4c2c87440e8c3a010a2c76ee4a8ea5c6cf8d1360ef407bcaebcb84dc05329e458a279eb480b74c575ba435b971bb6cb7b1b11bb50e99fdfe8723a8d05c2945c0ed83ebfc62a1adb9e9cc3805b63726e08bc74676c239c936a40ed3ddb1b63d15ca9f5beeb699b92169e7ef17057c8');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (539, 17400, 'Lofexidine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (540, 7568, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (541, 10128, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (542, 16270, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'789c8d524b76c33008bc0a07e8e70c7dbd4017bd00b6714c230917a4a4be7d418e5ff2baea0e49c330cce85dca28992b960acd086406ab58b940a68947afa4c095eb02d6060b186382ef164565b268c034ca2209326ec065544227aa0b81b29d03b0d0ea44a33f7e35dd5e003e158b31f9cc036f5e8191b60c351e3173e9d70b5e0806a2024aab68a5e9266757199ab1f8ddc2a90ff5f39df344851453dabcd924399328705e55bcec34a3f822a539abf72aae5b201006659a9da8926a5bbb093eec0679ea053d4a433fae6235a39ec9094f37b5dd9f19ab7b162a8b94e7fd74583223a7a6a119e2c22d31a8780e867d4373bb3e8e97eb22a1d85aa67fe4e1135f7d9b2e136161aba25b00125f486162eb49456c8323ee614c7b727334ff8dee6dacdefd87c281add0cf9a904b58f9902050a24bff4606e15218ae0e3b3e97af2b0f61fa845f692af5fc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (543, 16271, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (544, 16272, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (545, 21861, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'789c8d524b76c33008bc0a07e8e70c7dbd4017bd00b6714c230917a4a4be7d418e5ff2baea0e49c330cce85dca28992b960acd086406ab58b940a68947afa4c095eb02d6060b186382ef164565b268c034ca2209326ec065544227aa0b81b29d03b0d0ea44a33f7e35dd5e003e158b31f9cc036f5e8191b60c351e3173e9d70b5e0806a2024aab68a5e9266757199ab1f8ddc2a90ff5f39df344851453dabcd924399328705e55bcec34a3f822a539abf72aae5b201006659a9da8926a5bbb093eec0679ea053d4a433fae6235a39ec9094f37b5dd9f19ab7b162a8b94e7fd74583223a7a6a119e2c22d31a8780e867d4373bb3e8e97eb22a1d85aa67fe4e1135f7d9b2e136161aba25b00125f486162eb49456c8323ee614c7b727334ff8dee6dacdefd87c281add0cf9a904b58f9902050a24bff4606e15218ae0e3b3e97af2b0f61fa845f692af5fc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (546, 21862, 'Lovastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.  ', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (547, 7568, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (548, 10128, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (549, 16270, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (550, 16271, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c6d53416e1b310cfc0a8f2d10a440910f142d7aeea11fa0b5b4cd5a2b6d49c9cee6f51dcaded8407ab26993c3e1cce8173795d29c4c92e859cb81da518c97952eda8e94eb99bda1a93c91eb7c2faa6164a255f00b9926a14f97a3a623a55a1a6bf187d1cfe4c7daf3443b219eceea186c95f85c758a7531e37d5e9ad642754f07ec97bd756dc4657a2cff746c7a26fa99fb9dca62fc50687ba862dcaabf37139bd02c8d7735eb1b68ec56aa713049795b67f13131f31a5417933da4d865b0ce4dac00e18c16c0789d059f13149b3a6707a56f39d3f251cddbde4dd4ff0ab158c5f179c5d8522d8e5ea917795d328444cbdc3d81c4c271529332818bb8870717e1537cc7e16c4d53cf6c00d23d714a40e5a2d72bf772167bc269c0748933bf607c623b41fd5cc3cb6ed8864b7e7fe03aa987ad5a3ada809d4ce22aa19316069a3a80ed2413564b9633b7e81b5713ef5c0ae2015fbd99945ebb93bc8aa5e0010ec09bd70ae98e6b000d3b2ef19f775f24055430553e940ac186d45e9fee62df788a0e23619a4128da43d441a0fb585eb9d1ceb80c8703f79662172807c257b2d3ac45c19347169b4624a01e66f348fad7f0eb85b0d17c28514bea86b3dad893b894da86bd11eec1f63bf701764bd5f07d84ea729402806da78407e3d11d4cf04f130e7ef7425ec12bb508db8fea112e4cf4b4bd9ae0bfa5fcea6ed6595bf47d785f1be4f5796d15721878be5135f9dbd5ae9643382de0c8d77d30eadd9ee77fbdbd93ef', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (551, 16272, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (552, 21861, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (553, 21862, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (554, 7568, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (555, 10128, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (556, 16270, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (557, 16271, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (558, 16272, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (559, 21861, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (560, 21862, 'Lovastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'green tea', 'Major', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909ca10b0889bb8ad256297d8a1b03d29a8a29f27bf3bbf2bb51053147a6364507e8ad378676c0b2b92512ea2e2c1953336890573e57e0926583d057e45a5143e003773d119bdd1d277dc26c4c2f0a0100569bef4ea5d8ac4ce25536f653dc8ff64074f69adb6eff9a15af9d164b792a99310ed8ef4fb270e6fbe720acec307dc10532b', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (561, 616, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (562, 617, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (563, 618, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (564, 3133, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (565, 3134, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (566, 6776, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (567, 6777, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (568, 7547, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (569, 7553, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (570, 21241, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (571, 22049, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (572, 22050, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (573, 22054, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (574, 22056, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (575, 22057, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (576, 22064, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (577, 22065, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (578, 22066, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (579, 22084, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (580, 22085, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (581, 25862, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (582, 26503, 'Losartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (583, 616, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (584, 617, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (585, 618, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (586, 3133, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (587, 3134, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (588, 6776, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (589, 6777, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'789c55504b6ac33010bdca5bb6e0e40eed2e8b42e90d26d2b33558968c6694e2db57ee22b4ab61e0fd3f6a6413e7c5eb25e99210952eed80169795a833f6ea62a67d9b40db1954723e60921dd6efe6eadd6913363959a1518cf04434b5f51448c7ceb64ae6a63210b0ba11bbb8b2b8e13b554823ba69592065d1ea2ce3c1ed86c6c0dd6bc33dd7b0b2195edebedeedf50a9c17410af656b741f96fe3a9d53eea68497a57d75ace24ffd52f5a620f8c901cab395b2d84713438f1c3e2f39951fd5c46eefc6d9a28cd318be6de3821321d718c38481346d6c62279385b9f670d43211c48f22004cb5867183da7897c30d7fd6cfe37fef507f4fb9672');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (590, 7547, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (591, 7553, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (592, 21241, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (593, 22049, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (594, 22050, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (595, 22054, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (596, 22056, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (597, 22057, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (598, 22064, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (599, 22065, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (600, 22066, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (601, 22084, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (602, 22085, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (603, 25862, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (604, 26503, 'Losartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.  Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c8d8c410ec2300c04bfb22fe83738c2174ce2b446a95d390ed0df1344853872dbd5cece854258a3e1b1189ce75ec9eb8e64dafaca989d362ede6510a4f9a7e3d62531da62bd665c19aba98439671473500d7e672e4512a51d5650ad9107e9049cfef7d2dd240f9394414274782985d8c80dadb78d53701eceb393ce7cfcc7a616e0e76746d8f73abd00eed85aa8', NULL, X'789c55504b6ac33010bdca5bb6e0e40eed2e8b42e90d26d2b33558968c6694e2db57ee22b4ab61e0fd3f6a6413e7c5eb25e99210952eed80169795a833f6ea62a67d9b40db1954723e60921dd6efe6eadd6913363959a1518cf04434b5f51448c7ceb64ae6a63210b0ba11bbb8b2b8e13b554823ba69592065d1ea2ce3c1ed86c6c0dd6bc33dd7b0b2195edebedeedf50a9c17410af656b741f96fe3a9d53eea68497a57d75ace24ffd52f5a620f8c901cab395b2d84713438f1c3e2f39951fd5c46eefc6d9a28cd318be6de3821321d718c38481346d6c62279385b9f670d43211c48f22004cb5867183da7897c30d7fd6cfe37fef507f4fb9672');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (605, 11849, 'Lorlatinib', 'Grapefruit and grapefruit juice may significantly increase the plasma concentrations of lorlatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (606, 13897, 'Lorlatinib', 'Grapefruit and grapefruit juice may significantly increase the plasma concentrations of lorlatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (607, 22082, 'Loxapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d505d4e04210cbe4a0fa07b07e3bb31f1045da6b334423b9632eb787a0babab0f2450be7e7fafe84ce20d8c12f1ce7281e797b7474cce3b015ee65fcbdacb0267822b9ad002ba82676ec0e26403ab02280be0b2738b7f57c05d398006852b3b2495d6eb3691b18d2569d6720278aae75ed0d50ed87ebdfce925edd2a8fca7ccf885b6686f304d72ec0cf71f9d6db84f5ab7424e50830a4b2891b9506bd360d5500a8cdac282d34d17e71271e88077d12be438f16af7f4b8ae947ccceac324092ba2ceeb31666cb0e5a3716214e0f546449f1b59644914d714e2a3cc10de4c8bca25e244c94093b8c50afaadca952c3a66cf3fcca25647867bd0d337690fa19b', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (608, 22083, 'Loxapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (611, 9850, 'Lurasidone', 'Grapefruit juice may significantly increase the plasma concentrations of lurasidone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658d310e02310c04bfb225342724c42f28f882491c6230f62976b8ef23448344359a66e642296c19c8c1945cb14976e81c1452dd18d17d6a05bd5c2a8a5bcce79ae2066fb80d5ab98d2909b2faabf7298541818d553f242dde5d17e0fcd7be32921e6cdf7773afd851429922713c1d50487d08c77e7903ab5a3ff5', NULL, X'789c3d8f318ec3300c04bfb21f481020b9070457a4bd22cd95b44cdb3c48a4205208fcfbc829ae256676978f469597d625f0d725310aed7059551649a4917788a6c6e48cd81835931742324dacd128c4d4610b726fe4329bf219781e64b36ace330aa78d54bc407c846d32c9611dd2f7efcfedeb82ebfd762a3c0bc5c017691ea74aeec30c9a2c7f54fdd4af3df0a29c31ed48dc82c63d59a9d675f651c93e561df0faffd7f90d819353b1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (612, 10106, 'Lurasidone', 'Grapefruit juice may significantly increase the plasma concentrations of lurasidone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658d310e02310c04bfb225342724c42f28f882491c6230f62976b8ef23448344359a66e642296c19c8c1945cb14976e81c1452dd18d17d6a05bd5c2a8a5bcce79ae2066fb80d5ab98d2909b2faabf7298541818d553f242dde5d17e0fcd7be32921e6cdf7773afd851429922713c1d50487d08c77e7903ab5a3ff5', NULL, X'789c3d8f318ec3300c04bfb21f481020b9070457a4bd22cd95b44cdb3c48a4205208fcfbc829ae256676978f469597d625f0d725310aed7059551649a4917788a6c6e48cd81835931742324dacd128c4d4610b726fe4329bf219781e64b36ace330aa78d54bc407c846d32c9611dd2f7efcfedeb82ebfd762a3c0bc5c017691ea74aeec30c9a2c7f54fdd4af3df0a29c31ed48dc82c63d59a9d675f651c93e561df0faffd7f90d819353b1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (613, 28600, 'Lurasidone', 'Grapefruit juice may significantly increase the plasma concentrations of lurasidone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658d310e02310c04bfb225342724c42f28f882491c6230f62976b8ef23448344359a66e642296c19c8c1945cb14976e81c1452dd18d17d6a05bd5c2a8a5bcce79ae2066fb80d5ab98d2909b2faabf7298541818d553f242dde5d17e0fcd7be32921e6cdf7773afd851429922713c1d50487d08c77e7903ab5a3ff5', NULL, X'789c3d8f318ec3300c04bfb21f481020b9070457a4bd22cd95b44cdb3c48a4205208fcfbc829ae256676978f469597d625f0d725310aed7059551649a4917788a6c6e48cd81835931742324dacd128c4d4610b726fe4329bf219781e64b36ace330aa78d54bc407c846d32c9611dd2f7efcfedeb82ebfd762a3c0bc5c017691ea74aeec30c9a2c7f54fdd4af3df0a29c31ed48dc82c63d59a9d675f651c93e561df0faffd7f90d819353b1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (614, 30460, 'Lurasidone', 'Grapefruit juice may significantly increase the plasma concentrations of lurasidone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658d310e02310c04bfb225342724c42f28f882491c6230f62976b8ef23448344359a66e642296c19c8c1945cb14976e81c1452dd18d17d6a05bd5c2a8a5bcce79ae2066fb80d5ab98d2909b2faabf7298541818d553f242dde5d17e0fcd7be32921e6cdf7773afd851429922713c1d50487d08c77e7903ab5a3ff5', NULL, X'789c3d8f318ec3300c04bfb21f481020b9070457a4bd22cd95b44cdb3c48a4205208fcfbc829ae256676978f469597d625f0d725310aed7059551649a4917788a6c6e48cd81835931742324dacd128c4d4610b726fe4329bf219781e64b36ace330aa78d54bc407c846d32c9611dd2f7efcfedeb82ebfd762a3c0bc5c017691ea74aeec30c9a2c7f54fdd4af3df0a29c31ed48dc82c63d59a9d675f651c93e561df0faffd7f90d819353b1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (615, 30461, 'Lurasidone', 'Grapefruit juice may significantly increase the plasma concentrations of lurasidone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658d310e02310c04bfb225342724c42f28f882491c6230f62976b8ef23448344359a66e642296c19c8c1945cb14976e81c1452dd18d17d6a05bd5c2a8a5bcce79ae2066fb80d5ab98d2909b2faabf7298541818d553f242dde5d17e0fcd7be32921e6cdf7773afd851429922713c1d50487d08c77e7903ab5a3ff5', NULL, X'789c3d8f318ec3300c04bfb21f481020b9070457a4bd22cd95b44cdb3c48a4205208fcfbc829ae256676978f469597d625f0d725310aed7059551649a4917788a6c6e48cd81835931742324dacd128c4d4610b726fe4329bf219781e64b36ace330aa78d54bc407c846d32c9611dd2f7efcfedeb82ebfd762a3c0bc5c017691ea74aeec30c9a2c7f54fdd4af3df0a29c31ed48dc82c63d59a9d675f651c93e561df0faffd7f90d819353b1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (616, 31523, 'Lurasidone', 'Grapefruit juice may significantly increase the plasma concentrations of lurasidone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658d310e02310c04bfb225342724c42f28f882491c6230f62976b8ef23448344359a66e642296c19c8c1945cb14976e81c1452dd18d17d6a05bd5c2a8a5bcce79ae2066fb80d5ab98d2909b2faabf7298541818d553f242dde5d17e0fcd7be32921e6cdf7773afd851429922713c1d50487d08c77e7903ab5a3ff5', NULL, X'789c3d8f318ec3300c04bfb21f481020b9070457a4bd22cd95b44cdb3c48a4205208fcfbc829ae256676978f469597d625f0d725310aed7059551649a4917788a6c6e48cd81835931742324dacd128c4d4610b726fe4329bf219781e64b36ace330aa78d54bc407c846d32c9611dd2f7efcfedeb82ebfd762a3c0bc5c017691ea74aeec30c9a2c7f54fdd4af3df0a29c31ed48dc82c63d59a9d675f651c93e561df0faffd7f90d819353b1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (621, 8617, 'Meclizine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (622, 22430, 'Meclizine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (623, 24890, 'Meclofenamic acid', 'The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c1dccc10d02310c05d1567e05f480c4850b42a20293788985d78e6c2fb44fc4799ee64e256c95c8e187763c19cd0f4b56ee70430d494caf65841462c541ad6425b20eea1fc925cb11bc0589610bdf41da7cb8ae97e5b1cfbfff0e5146d15bec05ca29b1b4076e8ff3f592a71f28d03376', NULL, X'789c1d8f316ec3300c45aff2c76468ee50a040e0a54b73015aa26d02121988348adc3e54262dff3d3e3d0e46312de718ac81d319b681fc29431436a0a61e3c4c2a3590867c896e8d7aa7b0f1421de7eeb8fcfe7d2f3f7ecd4105c7416a0d9d5e684c1561d8c9231d1aec219aa6cb7db9626d6615cddc6fc0234b3a9764c5fb075e19f5e4895336f65594e7ba24cedbc625b213ffdcda7c450f5925c4747ee039cc83f6963da2fec910dda7aa72194c9ea659b30f89d70422afdf1734d1dcddde00af648e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (624, 7659, 'Mefenamic acid', 'The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c1dccc10d02310c05d1567e05f480c4850b42a20293788985d78e6c2fb44fc4799ee64e256c95c8e187763c19cd0f4b56ee70430d494caf65841462c541ad6425b20eea1fc925cb11bc0589610bdf41da7cb8ae97e5b1cfbfff0e5146d15bec05ca29b1b4076e8ff3f592a71f28d03376', NULL, X'789c1d8f316ec3300c45aff2c76468ee50a040e0a54b73015aa26d02121988348adc3e54262dff3d3e3d0e46312de718ac81d319b681fc29431436a0a61e3c4c2a3590867c896e8d7aa7b0f1421de7eeb8fcfe7d2f3f7ecd4105c7416a0d9d5e684c1561d8c9231d1aec219aa6cb7db9626d6615cddc6fc0234b3a9764c5fb075e19f5e4895336f65594e7ba24cedbc625b213ffdcda7c450f5925c4747ee039cc83f6963da2fec910dda7aa72194c9ea659b30f89d70422afdf1734d1dcddde00af648e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (625, 18838, 'Mefenamic acid', 'The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c1dccc10d02310c05d1567e05f480c4850b42a20293788985d78e6c2fb44fc4799ee64e256c95c8e187763c19cd0f4b56ee70430d494caf65841462c541ad6425b20eea1fc925cb11bc0589610bdf41da7cb8ae97e5b1cfbfff0e5146d15bec05ca29b1b4076e8ff3f592a71f28d03376', NULL, X'789c1d8f316ec3300c45aff2c76468ee50a040e0a54b73015aa26d02121988348adc3e54262dff3d3e3d0e46312de718ac81d319b681fc29431436a0a61e3c4c2a3590867c896e8d7aa7b0f1421de7eeb8fcfe7d2f3f7ecd4105c7416a0d9d5e684c1561d8c9231d1aec219aa6cb7db9626d6615cddc6fc0234b3a9764c5fb075e19f5e4895336f65594e7ba24cedbc625b213ffdcda7c450f5925c4747ee039cc83f6963da2fec910dda7aa72194c9ea659b30f89d70422afdf1734d1dcddde00af648e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (626, 22457, 'Mefenamic acid', 'The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c1dccc10d02310c05d1567e05f480c4850b42a20293788985d78e6c2fb44fc4799ee64e256c95c8e187763c19cd0f4b56ee70430d494caf65841462c541ad6425b20eea1fc925cb11bc0589610bdf41da7cb8ae97e5b1cfbfff0e5146d15bec05ca29b1b4076e8ff3f592a71f28d03376', NULL, X'789c1d8f316ec3300c45aff2c76468ee50a040e0a54b73015aa26d02121988348adc3e54262dff3d3e3d0e46312de718ac81d319b681fc29431436a0a61e3c4c2a3590867c896e8d7aa7b0f1421de7eeb8fcfe7d2f3f7ecd4105c7416a0d9d5e684c1561d8c9231d1aec219aa6cb7db9626d6615cddc6fc0234b3a9764c5fb075e19f5e4895336f65594e7ba24cedbc625b213ffdcda7c450f5925c4747ee039cc83f6963da2fec910dda7aa72194c9ea659b30f89d70422afdf1734d1dcddde00af648e');